pretickt

Labcorp Holdings Inc. (LH)

Healthcare · end-of-day data as of Oct 16, 2026

Labcorp Holdings Inc.
LH · $25.79B
$317.95+7.4%last 60 sessions · close Oct 16, 2026
$244.17$338.6152 weeks
Buy · 18 analystsPT $336.42 +5.8%
  • P/E vs own+6.3%
  • P/E vs sector-6.6%
  • Target upside+5.8%
  • Off 52w high-6.1%
  • Insiders-$3.17M
  • FCF yield+4.5%
  • Earnings in12d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI53
  • MA20×50—
  • Volume1.0x
  • Support-4.0%
  • Resistance+1.0%

The average 12-month analyst price target for LH is $336.42, 5.8% above the last close of $317.95 on Oct 16, 2026; targets range from $298.54 to $385.09. Rating consensus: Buy.

Snapshot

  • P/E26.3x
  • P/E vs sector-6.6%
  • P/E vs own+6.3%
  • Target upside+5.8%
  • ConsensusBuy
  • Market cap$25.79B
  • FCF yield+4.5%
  • Insiders-$3.17M
  • Earnings in12d
  • News

Why it moved

Labcorp Holdings Inc. (LH) fell 2.2% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to LH.

Market (SPY)-1.1%
Healthcare sector+0.4%
LH specific-1.5%

1 story on the day (30-day average 0.5).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$250$278$305$332Oct 25Jan 26Apr 26Jul 26Oct 26EDEDEDEDE

Last close $317.95 · +13.2% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendbullish
  • Sector▲ +16.0%
  • MAs20▲ 50▼ 100▲ 200▲
  • Above MAs3 of 4 above
  • MA20×50—
  • RSI53
  • Support-4.0%
  • Resistance+1.0%
  • Off 52w high-6.1%
  • Off ATH-6.1%
  • 52w range$317.95
  • Bollingerupper half
  • MACD1.46
  • ATR+2.2%
  • Volume1.0x

Analyst price targets

Low$298.54
Average$336.42
Median$336.98
High$385.09
Upside+5.8%

10 firms with a target in the last 12 months · last close $317.95 · as of Oct 16, 2026

⇔⇕$237$276$315$353$392Oct 25Feb 26Jun 26Oct 26Feb 27Jun 27-1%-1%-1%+8%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 2 · Buy 11 · Hold 4 · Sell 0 · Strong sell 1

Revenue and free cash flow

Q2 FY2026: Revenue +5.8% year over year, free cash flow 8.4% of revenue, operating margin 12.1%.

RevenueFree cash flow
Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$3.73B3.64$314M29.8%12.1%8.0%
Q1 FY2026Mar 31, 2026$3.54B3.35$70.5M26.5%10.9%7.9%
Q4 FY2025Dec 31, 2025$3.52B1.98$490M26.2%10.9%4.7%
Q3 FY2025Sep 30, 2025$3.56B3.12$281M28.8%11.1%7.3%
Q2 FY2025Jun 30, 2025$3.53B2.84$543M29.7%11.2%6.7%
Q1 FY2025Mar 31, 2025$3.35B2.52-$108M28.3%9.7%6.4%
Q4 FY2024Dec 31, 2024$3.33B1.70$665M26.9%6.5%4.3%
Q3 FY2024Sep 30, 2024$3.28B2.01$162M27.6%7.7%5.2%

Peers

20D
1IDXXIDEXX Laboratories, Inc.$560.36+2.4%-26.9%+34.9%39.7$44.15B
2IQVIQVIA Holdings Inc.$266.90-1.5%-3.0%+3.6%33.1$43.93B
3WATWaters Corporation$436.95-1.6%-1.6%+4.4%109.0$42.9B
4ILMNIllumina, Inc.$262.54-2.0%-10.6%-16.6%49.0$39.64B
5MTDMettler-Toledo International Inc.$1,622.29-1.0%-1.0%-7.3%36.5$32.51B
6DGXQuest Diagnostics Incorporated$235.00-1.7%-4.7%-0.5%24.9$25.94B
7LHLabcorp Holdings Inc.$317.95-2.2%-6.1%+5.8%26.3$25.79B
8RVTYRevvity, Inc.$152.64-1.3%-3.0%-18.2%72.7$17.03B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.